Skip to main content
Autobound logo
Johnson & Johnson8-K: Restructuring

EVP & Worldwide Chairman of Innovative Medicine Jennifer Taubert to retire Sept 1, 2026

Read at SEC EDGAR

Source

SEC EDGARAug 4, 2026

Current report (Form 8-K)

Johnson & Johnson 8-K

Filing excerpt

On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.

sec.gov/Archives/edgar/data/200406/000020040626000167/jnj-20260804.htmRead the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Fiscal year end
08/04
Filed
Aug 4, 2026

More from Johnson & Johnson

Company page →

More 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
200406
Accession number
0000200406-26-000167
Timeframe
Current quarter
Filing year
2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
90%
Sentiment
Neutral
Detected
Aug 11, 2026
signal_type
sec-8k
signal_subtype
restructuring

Use this data

Get every 8-K signal for Johnson & Johnson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/d30cab23-7dec-438f-b653-af2eb9774640 returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.

{
  "signal_id": "d30cab23-7dec-438f-b653-af2eb9774640",
  "signal_type": "sec-8k",
  "signal_subtype": "restructuring",
  "detected_at": "2026-08-11T08:05:54.791+00:00",
  "company": {
    "name": "Johnson & Johnson",
    "domain": "jnj.com"
  },
  "data": {
    "detail": "The departure of a key executive overseeing the global Innovative Medicine division creates a significant opportunity. New leadership will likely re-evaluate existing strategies, budgets, and vendor relationships, creating a window for new solution providers in the 90 days following the transition.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "summary": "EVP & Worldwide Chairman of Innovative Medicine Jennifer Taubert to retire Sept 1, 2026",
    "excerpts": "On August 4, 2026, the Company announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine and member of the Executive Committee effective September 1, 2026.",
    "relevance": 0.9,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000167/jnj-20260804.htm",
    "filing_date": "2026-08-04",
    "filing_year": 2026,
    "fiscal_year_end": "08/04",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.